(Q40869108)

24 September 2017

title

The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells (English)

1 reference

24 September 2017

R H Weiss

1

1 reference

24 September 2017

C J Randour

series ordinal

2

1 reference

24 September 2017

language of work or name

1 reference

1 June 2000

1 reference

24 September 2017

number of pages

6

1 reference

inferred from page(s)

published in

Cellular Signalling

1 reference

24 September 2017

volume

12

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

413-418

1 reference

A matter of life and cell death

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

New functional activities for the p21 family of CDK inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

p21-containing cyclin kinases exist in both active and inactive states

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

MEK inhibition augments Raf activity, but has variable effects on mitogenesis, in vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

Biological response to phorbol ester determined by alternative G1 pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

Sphingosine reverses growth inhibition caused by activation of protein kinase c in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

Mitogenic inhibition by phorbol esters is associated with decreased phosphatidylinositol-3 kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

Regulation of CDK/cyclin complexes during the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

p21: structure and functions associated with cyclin-CDK binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

Radiation-induced cell cycle arrest compromised by p21 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2800%2900081-4

7 January 2021

10.1016/S0898-6568(00)00081-4

Identifiers

DOI

1 reference

24 September 2017

1 reference